Biosearch Licenses Stellaris RNA FISH-based Technology from UMDNJ | GenomeWeb

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has acquired the exclusive worldwide rights to continuing Stellaris RNA FISH-based inventions from the University of Medicine and Dentistry of New Jersey.

The Stellaris technology has been extended to directly and quantitatively detect chromosomal diseases resulting from translocations and aberrant splice junctions and SNPs, as well as single-molecule detection of mRNA, long non-coding RNA, and viral RNAs, Biosearch said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.